[1] Renzulli M, Brandi N, Argalia G,et al. Morphological, dynamic and functional characteristics of liver pseudolesions and benign lesions. Radiol Med,2022,127(2):129-144. [2] Guo J, Jiang D, Qian Y,et al. Differential diagnosis of different types of solid focal liver lesions using two-dimensional shear wave elastography. World J Gastroenterol,2022,28(32):4716-4725. [3] Yang D, Zhuang B, Wang W,et al. Differential diagnosis of liver metastases of gastrointestinal stromal tumors from colorectal cancer based on combined tumor biomarker with features of conventional ultrasound and contrast-enhanced ultrasound. Abdom Radiol (NY),2020,45(9):2717-2725. [4] 陈天佑, 袁敏, 周粟,等. 3.0T动态增强磁共振灌注成像对小肝癌射频消融疗效评估的价值研究. 介入放射学杂志, 2022,31(2):154-159. [5] Zeng YN, Zhang BT, Song T,et al. The clinical value of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) semi-quantitative parameters in monitoring neoadjuvant chemotherapy response of osteosarcoma. Acta Radiol,2022,63(8):1077-1085. [6] Liu L, Hu L, Zeng Q,et al. Dynamic contrast-enhanced MRI of nasopharyngeal carcinoma: correlation of quantitative dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameters with hypoxia-inducible factor 1α expression and tumor grade/stage. Ann Palliat Med,2021,10(2):2238-2253. [7] Liu Z, Jiang Y, Yuan H,et al. The trends in incidence of primary liver cancer caused by specific etiologies: Results from theglobal burden of disease study 2016 and implications for liver cancer prevention. J Hepatol,2019,70(4):674-683. [8] Chen YG, Yang CW, Chung CH,et al. The association between metabolic risk factors, nonalcoholic fatty liver disease, and the incidence of liver cancer: a nationwide population-based cohort study. Hepatol Int,2022,16(4):807-816. [9] Yu XC, Liu JB, Tang QH,et al. Recent trends in the incidence and survival of stage I liver cancer: a surveillance, epidemiology, and end results analysis. Ann Med,2022,54(1):2785-2795. [10] Park J, Block M, Bock D,et al. A comparison of liver MRI and contrast-enhanced CT as standard workup before treatment for rectal cancer in usual care - a retrospective study. Curr Med Imaging,2022,18(2):256-262. [11] 吴旋音, 田果, 曹红翠,等. Sonazoid超声造影与增强磁共振成像对肝脏局灶性病变的诊断价值比较. 中华超声影像学杂志, 2021, 30(6):494-499. [12] 李炳荣, 张坤, 严小斌,等. 2018年版MRI肝脏影像报告和数据系统对≤3 cm肝细胞癌与其他肝脏原发恶性肿瘤的鉴别诊断价值. 中华放射学杂志, 2021,55(2):166-172. [13] Verma M, Sood S, Singh B,et al. Dynamic contrast-enhanced magnetic resonance perfusion volumetrics can differentiate tuberculosis of the spine and vertebral malignancy. Acta Radiol,2022,63(11):1504-1512. [14] Surov A, Kim JY, Aiello M,et al. Associations between dynamic contrast enhanced magnetic resonance imaging and clinically relevant histopathological features in breast cancer: a multicenter analysis. In Vivo,2022,36(1):398-408. [15] Bülbül HM, Bülbül O, Sarıo lu S, et al. Relationships between DCE-MRI, DWI, and 18F-FDG PET/CT parameters with tumor grade and stage in patients withhead and neck squamous cell carcinoma. Mol Imaging Radionucl Ther,2021,30(3):177-186. [16] Liu B, Hu L, Wang L,et al. Evaluation of microvascular permeability of skeletal muscle and texture analysis based on DCE-MRI in alloxan-induced diabetic rabbits. Eur Radiol, 2021,31(8):5669-5679. [17] Li X, Wu S, Li D,et al. Intravoxel incoherent motion combined with dynamic contrast-enhanced perfusion MRI of early cervical carcinoma: correlations between multimodal parameters and HIF-1α expression. J Magn Reson Imaging,2019,50(3):918-929. [18] 窦瑞欣, 张晓曦, 田淼,等. DCE-MRI定量参数用于肝细胞癌与肝良性占位的诊断效能分析. 临床放射学杂志, 2019,38(4):638-641. [19] Xu XQ, Qian W, Hu H,et al. Histogram analysis of dynamic contrast-enhanced magnetic resonance imaging for differentiating malignant from benign orbital lymphproliferative disorders. Acta Radiol,2019,60(2):239-246. [20] Chatterjee A, Gallan AJ, He D,et al. Revisiting quantitative multi-parametric MRI of benign prostatic hyperplasia and its differentiation from transition zone cancer. Abdom Radiol (NY),2019,44(6):2233-2243. |